ATE406161T1 - Kombination aus tenofovir, ritonavir und tmc114 - Google Patents

Kombination aus tenofovir, ritonavir und tmc114

Info

Publication number
ATE406161T1
ATE406161T1 AT05774136T AT05774136T ATE406161T1 AT E406161 T1 ATE406161 T1 AT E406161T1 AT 05774136 T AT05774136 T AT 05774136T AT 05774136 T AT05774136 T AT 05774136T AT E406161 T1 ATE406161 T1 AT E406161T1
Authority
AT
Austria
Prior art keywords
tenofovir
ritonavir
combination
tmc114
hiv
Prior art date
Application number
AT05774136T
Other languages
English (en)
Inventor
Richard Hoetelmans
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Application granted granted Critical
Publication of ATE406161T1 publication Critical patent/ATE406161T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Aiming, Guidance, Guns With A Light Source, Armor, Camouflage, And Targets (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT05774136T 2004-07-08 2005-07-08 Kombination aus tenofovir, ritonavir und tmc114 ATE406161T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04103256 2004-07-08

Publications (1)

Publication Number Publication Date
ATE406161T1 true ATE406161T1 (de) 2008-09-15

Family

ID=34929311

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05774136T ATE406161T1 (de) 2004-07-08 2005-07-08 Kombination aus tenofovir, ritonavir und tmc114

Country Status (19)

Country Link
US (1) US20070208009A1 (de)
EP (1) EP1765337B1 (de)
JP (1) JP2008505870A (de)
CN (1) CN1984654A (de)
AT (1) ATE406161T1 (de)
AU (1) AU2005261701A1 (de)
BR (1) BRPI0513051A (de)
CA (1) CA2572551A1 (de)
DE (1) DE602005009366D1 (de)
DK (1) DK1765337T3 (de)
ES (1) ES2313394T3 (de)
HR (1) HRP20080612T3 (de)
MX (1) MXPA06014930A (de)
NZ (1) NZ551841A (de)
PL (1) PL1765337T3 (de)
RU (1) RU2368380C2 (de)
SI (1) SI1765337T1 (de)
WO (1) WO2006005720A1 (de)
ZA (1) ZA200700176B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060135562A1 (en) * 2004-11-16 2006-06-22 Boehringer Ingelheim International Gmbh Method for treating HIV infection through co-administration of tipranavir and darunavir
US20100285115A1 (en) * 2007-10-29 2010-11-11 Cipla Limited Novel Antiretroviral Combination
PA8809601A1 (es) * 2007-12-24 2009-07-23 Cipla Ltd Combinación anti-retroviral
CN102876714A (zh) * 2011-09-07 2013-01-16 深圳市易瑞生物技术有限公司 用慢病毒检测hiv耐药表型
WO2013057469A1 (en) * 2011-10-20 2013-04-25 Cipla Limited Pharmaceutical antiretroviral compositions
KR20150084772A (ko) * 2012-10-23 2015-07-22 시플라 리미티드 약학 항레트로바이러스 조성물
WO2014184553A1 (en) * 2013-05-15 2014-11-20 Cipla Limited Pharmaceutical antiretroviral compositions
MX2016002560A (es) * 2013-08-29 2016-10-26 Teva Pharma Forma de dosificacion unitaria que comprende emtricitabina, tenofovir, darunavir y ritonavir y un comprimido monolitico que comprende darunavir y ritonavir.
CA2942877A1 (en) * 2014-04-08 2015-10-15 Nitzan SHAHAR Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir
GB201509431D0 (en) * 2015-06-01 2015-07-15 Equigerminal Sa Antiviral composition
US10213507B2 (en) * 2017-03-10 2019-02-26 The Florida International University Board Of Trustees Compositions and methods for treating HIV-associated neurocognitive disorders
RU2662160C9 (ru) * 2017-07-03 2018-10-22 Александрович Иващенко Андрей Комбинированный лекарственный препарат для терапии вирусных инфекций

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI286476B (en) * 2001-12-12 2007-09-11 Tibotec Pharm Ltd Combination of cytochrome P450 dependent protease inhibitors

Also Published As

Publication number Publication date
BRPI0513051A (pt) 2008-04-22
US20070208009A1 (en) 2007-09-06
NZ551841A (en) 2009-04-30
EP1765337A1 (de) 2007-03-28
SI1765337T1 (sl) 2009-02-28
RU2368380C2 (ru) 2009-09-27
MXPA06014930A (es) 2007-02-28
DE602005009366D1 (de) 2008-10-09
JP2008505870A (ja) 2008-02-28
CN1984654A (zh) 2007-06-20
AU2005261701A1 (en) 2006-01-19
ZA200700176B (en) 2008-04-30
WO2006005720A1 (en) 2006-01-19
RU2007104774A (ru) 2008-08-20
HRP20080612T3 (en) 2009-01-31
PL1765337T3 (pl) 2009-02-27
EP1765337B1 (de) 2008-08-27
ES2313394T3 (es) 2009-03-01
CA2572551A1 (en) 2006-01-19
DK1765337T3 (da) 2009-01-05

Similar Documents

Publication Publication Date Title
ATE406161T1 (de) Kombination aus tenofovir, ritonavir und tmc114
HUS1700003I1 (hu) Pirimidinamin-származékok és ezeket tartalmazó gyógyászati készítmények, mint angiogenézis modulátorok
CY1107419T1 (el) Προφαρμακα αντι-ιικων μεσων απο πιπεραζινη και υποκατεστημενη πιπεριδινη
NO20042298L (no) Farmasoytiske preparater og deres anvendelser
PT1318791E (pt) Composicao farmaceutica semi-solida de isotretinoina
MXPA05002814A (es) Formulacion para agentes lipofilicos.
MY144318A (en) Methods of treating hiv infection.
SE0102315D0 (sv) Compounds
TR200103575T2 (tr) Sülfonamid ve sülfamid ikameli/katkılı imidazokinolinler
SE0301700D0 (sv) Novel compounds
CY1113003T1 (el) Ευσταθη παρασκευασματα laquinimod
DE60334773D1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
NO20053855D0 (no) 1-fenylalkankarboksylsyrederivater til behandling av neurodegenerative sykdommer.
NO20045323L (no) Antistoffer
CO5660287A2 (es) Derivados de tetrahidrocarbazol y su uso farmaceutico
IS8051A (is) Kladríbínefnablöndur til inngjafar um munn
WO2006034001A3 (en) Methods of treating hiv infection
ITRM20030363A1 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico di esse.
WO2002026726A3 (en) Antiviral compositions and methods of use
ATE213233T1 (de) Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit
ATE353231T1 (de) Pharmazeutische zusammensetzungen
DK1273301T3 (da) Farmaceutiske præparater baseret på aktive bestanddele der kan anvendes til ulovlig administration
AP2001002369A0 (en) Pharmaceutical complex.
TW200610526A (en) Novel hydrophilic analogs of 4,8-dihydrobenzodithiophene-4,8-diones as anticancer agents
DE602004008051D1 (de) Aus einer bifidobakterien-kultur gewonnener immunomodulator und diesen enthaltende zusammensetzungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1765337

Country of ref document: EP

REN Ceased due to non-payment of the annual fee